December 29, 2021
With the Omicron variant of COVID-19 surging through the country, access to timely testing is becoming a major constraint to heading off the surge. The White House announced new measures to make at-home tests more readily available beginning in January. Unfortunately, a lot of questions remain as to how health insurers will pay for the over-the-counter tests. USA Today recently spoke with Rena Conti, Associate Professor of Markets, Public Policy, & Law to discuss the issues surrounding barriers to access.
“If consumers face out-of-pocket costs, even if they’re relatively cheap, the likelihood is that they won’t use the tests.”
Rena Conti
Associate Professor of MARKETS, PUBLIC POLICY, & LAW
